← Leaderboards
Kelly Y. Poe
Global Vaccines, Inc.
$560,171
Attributed
$560,171
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $226.4K · FY2006–10$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$560,171 · 2
By mechanism
R21$414,971 · 1
F32$145,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Global Vaccines, Inc.
Same institution · by research overlap
- Benjamin P Steil$92,824
- Daniel Tonkin$97,684
- Mario Barro$1,141,009
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyImmunityHiv-1Research StudyVaccinesLifeGenomeGenomicsImmunogenicityParticleVaccine SafetyVirusNeutralizing AntibodyCapsidAttenuatedGaggingAttenuated Live Virus VaccineCellsBaseBreedingAntigensBrainCytoplasmBlood Circulation
Grant awards (5)
A Propagating Chimeric Particle as a Safe Alternative to Live-Attenuated Virus$226,359
R21 · FY2010 · AI · contact PI
A Propagating Chimeric Particle as a Safe Alternative to Live-Attenuated Virus$188,612
R21 · FY2009 · AI · contact PI
Propagation Enhancement of Chimeric Lentiviral Vaccines$50,428
F32 · FY2008 · AI · contact PI
Propagation Enhancement of Chimeric Lentiviral Vaccines$48,796
F32 · FY2007 · AI · contact PI
Propagation Enhancement of Chimeric Lentiviral Vaccines$45,976
F32 · FY2006 · AI · contact PI